Coste y efectividad de los nuevos antivirales para la hepatitis C

Lens, Sabela; Bonacci, Martín.
Aten. prim. (Barc., Ed. impr.) ; 47(8): 479-481, oct. 2015. tab
Artículo en Español | IBECS (España) | ID: ibc-142353

Documentos relacionados

  1. [The Probabilistic Efficiency Frontier: A Value Assessment of Treatment Options in Hepatitis C].
  2. The Growing Problem of Hepatitis C Virus Infection: The Case of West Virginia.
  3. A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
  4. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
  5. Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.
  6. Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
  7. Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
  8. Engaging hepatitis C infected patients in cost-effectiveness analyses: A literature review.
  9. The Nobel Prize for discovery of HCV is a call to end hepatitis.
  10. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.